All practice questions

Match each classic clinical presentation of an obstetric complication with its most likely underlying etiology.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Placental abruption is characterized by painful bleeding and a rigid uterus. Placenta previa presents with painless bleeding and a soft uterus. Vasa previa features painless bleeding directly tied to membrane rupture with rapid fetal distress. Uterine rupture presents with sudden severe pain, loss of fetal station, and abrupt cessation of uterine contractions.

Each obstetric complication has a highly specific clinical hallmark: abruption features pain and hypertonus; previa features painless bleeding; vasa previa is tied to membrane rupture and fetal distress; and uterine rupture features loss of station and contraction cessation.

Step-by-Step Solution

1

Analyze the presentation for the presence or absence of maternal pain and uterine tenderness.

Painful bleeding suggests placental abruption or uterine rupture; painless bleeding suggests placenta previa or vasa previa.

Pain is a key initial differentiating factor in evaluating antepartum hemorrhage.

2

Evaluate the timing of bleeding relative to membrane rupture and fetal heart rate changes.

Bleeding immediately after rupture of membranes with rapid, severe fetal bradycardia points directly to vasa previa.

The bleeding in vasa previa is purely fetal, leading to rapid fetal exsanguination before maternal hemodynamic changes occur.

3

Assess labor progress and the uterine contraction pattern.

Loss of fetal station and sudden cessation of contractions are classic, life-threatening signs of uterine rupture.

When the myometrium completely tears, the uterus can no longer generate contractions, and the fetus may be extruded into the maternal abdomen.

Key Concept

Differentiating etiologies of antepartum hemorrhage and acute intrapartum emergencies based on classic clinical presentation features.

Question 6482Question →

Match each clinical presentation of non-anion gap metabolic acidosis (NAGMA) to its primary pathophysiological mechanism.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The correct matches align each clinical presentation with its underlying pathophysiological mechanism: the diarrhea patient with extrarenal bicarbonate loss; the Sjögren syndrome patient with impaired distal hydrogen secretion (Type 1 RTA); the diabetic patient with aldosterone deficiency/resistance (Type 4 RTA); the multiple myeloma patient with generalized proximal tubular dysfunction (Type 2 RTA); and the inhalant abuse patient with the excretion of unmeasured organic acid metabolites.

Each clinical vignette provides classic clues for a specific etiology of non-anion gap metabolic acidosis. The correct matches perfectly align the clinical scenario (diarrhea, Type 1 RTA, Type 4 RTA, Type 2 RTA/Fanconi, and Toluene toxicity) with their respective pathophysiological mechanisms by systematically applying the principles of urine electrolytes, urine pH, and serum potassium evaluation.

Step-by-Step Solution

1

Analyze the common presentation.

All five patients present with a hyperchloremic, non-anion gap metabolic acidosis (NAGMA).

Establishing the presence of NAGMA narrows the differential diagnosis to primarily gastrointestinal bicarbonate losses and renal tubular acidoses (RTAs).

2

Evaluate the urine anion gap (UAG).

The patient with diarrhea has a negative UAG (

-20\ mEq/L

), whereas all other patients have a positive UAG.

A negative UAG indicates that the kidneys are appropriately synthesizing and excreting ammonium (

NH_4^+

) with chloride to excrete the daily acid load, pointing to an extrarenal (GI) cause of acidosis.

3

Differentiate the classic renal tubular acidoses (RTAs) based on potassium and urine pH.

The diabetic patient has hyperkalemia (Type 4 RTA). The Sjögren patient has hypokalemia and urine pH > 5.5 (Type 1 RTA). The myeloma patient has glycosuria and phosphaturia (Type 2 RTA / Fanconi syndrome).

Type 4 RTA is uniquely characterized by hyperkalemia. Type 1 and Type 2 RTAs present with hypokalemia, but only Type 1 RTA features a strict inability to acidify the urine below a pH of 5.5.

4

Identify the toxicological mimic among the presentations.

The patient with a history of inhalant abuse (toluene) presents with a positive UAG but a high urine osmolal gap.

Toluene metabolism produces hippurate, which is excreted with

Na^+

or

K^+

rather than

Cl^-

. This creates a falsely positive UAG despite intact

NH_4^+

production (which is revealed by calculating the urine osmolal gap).

Key Concept

Evaluation of Non-Anion Gap Metabolic Acidosis (NAGMA) using serum potassium, urine pH, urine anion gap, and specific clinical contexts.

Question 6483Question →

A 21-year-old collegiate athlete is brought to the emergency department due to acute confusion, tinnitus, and severe nausea for the past 24 hours. He reports repeatedly taking "handfuls of pain pills" over the last three days to manage a severe ankle sprain. The patient has also had multiple episodes of forceful, non-bilious emesis today. His temperature is 38.0°C (100.4°F), heart rate is 115/min, blood pressure is 112/68 mm Hg, and respiratory rate is 32/min.

Laboratory Test	Result	Reference Range
Sodium ( $Na^+$ )	140 mEq/L	136-145 mEq/L
Potassium ( $K^+$ )	3.4 mEq/L	3.5-5.0 mEq/L
Chloride ( $Cl^-$ )	92 mEq/L	98-106 mEq/L
Bicarbonate ( $HCO_3^-$ )	16 mEq/L	22-28 mEq/L

Arterial Blood Gas (Room Air)	Result	Reference Range
pH	7.50	7.35-7.45
$PaCO_2$	21 mm Hg	35-45 mm Hg
$PaO_2$	98 mm Hg	75-105 mm Hg

Based on these findings, which of the following best describes this patient's acid-base disturbance?

Primary respiratory alkalosis, primary elevated anion gap metabolic acidosis, and primary metabolic alkalosis

Primary elevated anion gap metabolic acidosis with appropriate respiratory compensation

Primary respiratory alkalosis with appropriate metabolic compensation

Primary respiratory alkalosis and primary elevated anion gap metabolic acidosis only

Primary elevated anion gap metabolic acidosis and primary metabolic alkalosis only

Show answer & explanation

Answer: Primary respiratory alkalosis, primary elevated anion gap metabolic acidosis, and primary metabolic alkalosis

Answer

Primary respiratory alkalosis, primary elevated anion gap metabolic acidosis, and primary metabolic alkalosis

This patient's presentation and lab values indicate a classic triple acid-base disorder. The pH of 7.50 and

PaCO_2

of 21 mm Hg establish a primary respiratory alkalosis (due to central hyperventilation from salicylate toxicity). The anion gap of 32 establishes a primary high anion gap metabolic acidosis. Finally, the delta-delta calculation (

\Delta AG = 20

; Expected

HCO_3^- = 24 - 20 = 4

mEq/L) reveals that the actual

HCO_3^-

of 16 mEq/L is inappropriately high, proving the existence of a concurrent primary metabolic alkalosis caused by gastric acid loss from severe vomiting.

Step-by-Step Solution

1

Analyze the pH to determine the predominant acid-base status.

The pH is 7.50, which indicates alkalemia.

Identifying the primary direction of the pH shift helps isolate at least one of the primary disorders. Alkalemia means a primary alkalosis (either respiratory or metabolic) must be present.

2

Evaluate the

PaCO_2

in the context of the alkalemia.

The

PaCO_2

is 21 mm Hg (normal 40 mm Hg).

A low

PaCO_2

in the setting of alkalemia confirms the presence of a primary respiratory alkalosis. This is classically seen in salicylate toxicity due to direct stimulation of the medullary respiratory center.

3

Calculate the Anion Gap (AG) to assess for hidden metabolic acidosis.

AG = Na^+ - (Cl^- + HCO_3^-) = 140 - (92 + 16) = 32

.

An AG greater than 12 confirms the presence of a primary elevated anion gap metabolic acidosis (caused by uncoupling of oxidative phosphorylation and accumulation of lactic/salicylic acid).

4

Apply Winter's formula to determine expected respiratory compensation for the metabolic acidosis.

Expected\ PaCO_2 = (1.5 \times HCO_3^-) + 8 \pm 2 = (1.5 \times 16) + 8 \pm 2 = 32 \pm 2

mm Hg.

Since the actual

PaCO_2

(21 mm Hg) is significantly lower than the expected range (30-34 mm Hg), it confirms the primary respiratory alkalosis is an independent process, not just compensation.

5

Calculate the Delta Gap (

\Delta AG

) and expected

HCO_3^-

to check for a third disorder.

\Delta AG = Actual\ AG - Normal\ AG = 32 - 12 = 20

.

Expected\ HCO_3^- = 24 - 20 = 4

mEq/L.

If this were a pure high AG metabolic acidosis, the

HCO_3^-

should drop to 4 mEq/L. Because the actual

HCO_3^-

(16 mEq/L) is much higher than 4 mEq/L, there must be a concurrent process adding bicarbonate to the blood: a primary metabolic alkalosis due to severe vomiting.

Key Concept

Diagnosis of mixed triple acid-base disorders using the anion gap, Winter's formula, and the delta-delta ratio.

Question 6484Question →

Match the following patient laboratory profiles to the most likely underlying pathophysiologic mechanism of their calcium homeostasis abnormality.

Reference ranges:
Calcium: $8.4-10.2$ mg/dL
Intact PTH: $10-65$ pg/mL
Phosphorus: $2.5-4.5$ mg/dL
24-hour urine calcium: $100-300$ mg/day

Click a left item, then click its matching right item

Show answer & explanation

Answer

Profile 1 matches autonomous overproduction of PTH (Primary hyperparathyroidism). Profile 2 matches an inactivating mutation of the CaSR (Familial hypocalciuric hypercalcemia). Profile 3 matches ectopic secretion of a peptide that activates the PTH receptor (Humoral hypercalcemia of malignancy). Profile 4 matches decreased intestinal absorption of calcium (Secondary hyperparathyroidism).

Each laboratory profile distinctly matches a specific pathophysiologic mechanism of calcium imbalance. Primary hyperparathyroidism is characterized by autonomous PTH secretion causing hypercalcemia and hypercalciuria. FHH is caused by an inactivating CaSR mutation leading to hypercalcemia with paradoxical hypocalciuria. Humoral hypercalcemia of malignancy is driven by ectopic PTHrP, which suppresses endogenous PTH and causes hypophosphatemia. Finally, states of decreased intestinal calcium absorption (like vitamin D deficiency) lead to hypocalcemia and an appropriate compensatory rise in PTH (secondary hyperparathyroidism).

Step-by-Step Solution

1

Analyze the first laboratory profile (Calcium 11.2, PTH 85, Urine Ca 350).

The profile shows hypercalcemia, high PTH, and hypercalciuria.

This confirms PTH-dependent hypercalcemia. The high urine calcium differentiates primary hyperparathyroidism from familial hypocalciuric hypercalcemia (FHH).

2

Analyze the second laboratory profile (Calcium 11.1, PTH 75, Urine Ca 45).

The profile shows hypercalcemia, high PTH, and significant hypocalciuria.

Hypercalcemia with an inappropriately unsuppressed PTH and very low urine calcium (<100 mg/day) strongly suggests FHH, caused by an inactivating CaSR mutation.

3

Analyze the third laboratory profile (Calcium 12.5, PTH 5, Phos 2.1).

The profile shows severe hypercalcemia, suppressed PTH, and hypophosphatemia.

The suppressed intact PTH indicates a PTH-independent cause of hypercalcemia. The low phosphorus suggests a PTH-like effect, characteristic of PTHrP secretion in humoral hypercalcemia of malignancy.

4

Analyze the fourth laboratory profile (Calcium 7.8, PTH 90, Urine Ca 60).

The profile shows hypocalcemia, high PTH, and hypocalciuria.

Hypocalcemia stimulates a compensatory rise in PTH (secondary hyperparathyroidism). This is most often driven by poor intestinal calcium absorption due to vitamin D deficiency.

Key Concept

Differential diagnosis of calcium homeostasis disorders based on serum calcium, intact parathyroid hormone, and 24-hour urinary calcium excretion.

Question 6485Question →

During a preoperative evaluation clinic visit, an internal medicine physician is reviewing the medication list of an individual scheduled for an elective total hip replacement. The patient's past medical history includes heart failure with reduced ejection fraction, type 2 diabetes mellitus, a mechanical aortic valve replacement, and severe osteoarthritis. Match each of the patient's chronic medications to the most appropriate perioperative management strategy based on current clinical guidelines.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Warfarin requires bridging with low-molecular-weight heparin; Lisinopril should be held the morning of surgery; Bisoprolol must be continued through the morning of surgery; Dapagliflozin must be stopped 3-4 days prior to surgery.

Optimal perioperative management requires tailoring the handling of chronic medications to balance the risks of underlying disease exacerbation against the risks of anesthesia and surgical stress. Beta-blockers are maintained to prevent ischemia; ACE inhibitors are held to prevent severe vasoplegia; SGLT2 inhibitors are stopped early to avoid ketoacidosis; and warfarin is bridged for high-thrombotic-risk conditions.

Step-by-Step Solution

1

Assess the thromboembolic risk associated with the patient's mechanical aortic valve.

The risk is categorized as high, necessitating continuous therapeutic anticoagulation.

Determines that warfarin cannot simply be stopped; it requires bridging with low-molecular-weight heparin starting 5 days prior to the procedure.

2

Evaluate the risk of intraoperative hemodynamic instability for the patient's cardiac medications.

Lisinopril poses a risk of vasoplegic hypotension, while stopping bisoprolol risks rebound ischemia.

Guides the decision to hold the ACE inhibitor on the morning of surgery while continuing the beta-blocker uninterrupted.

3

Identify unique perioperative risks for the patient's diabetic medication.

Dapagliflozin can cause euglycemic diabetic ketoacidosis in the setting of fasting and surgical stress.

Mandates the proactive discontinuation of the SGLT2 inhibitor 3 to 4 days before the operation.

Key Concept

Perioperative Medication Management

Estimated Time:1m 30s

Question 6486Question →

A $48$ -year-old male is evaluated during a routine health maintenance visit. Three years prior, he underwent a transsphenoidal surgical resection for a pituitary macroadenoma, followed by targeted radiotherapy. His daily medication regimen includes hydrocortisone, testosterone gel, and levothyroxine. Recently, the patient has been experiencing worsening fatigue, unintended weight gain, and severe constipation. Vital signs are within normal limits. On physical examination, the physician notes a delayed relaxation phase of the Achilles tendon reflex bilaterally.

Laboratory studies obtained today show:

Test	Result	Reference Range
Thyroid-stimulating hormone (TSH)	$0.04$ $\mu$ U/mL	$0.4$ - $4.0$ $\mu$ U/mL
Free thyroxine (T4)	$0.7$ ng/dL	$0.9$ - $1.7$ ng/dL

Which of the following is the most appropriate next step in the management of this patient's medication regimen?

Increase the levothyroxine dosage

Decrease the levothyroxine dosage

Maintain the current levothyroxine dosage

Discontinue levothyroxine and initiate methimazole

Add liothyronine to the medication regimen

Show answer & explanation

Answer: Increase the levothyroxine dosage

Answer

Increase the levothyroxine dosage

In patients with intact pituitary function, primary hypothyroidism is managed by titrating levothyroxine to normalize the TSH level. However, in patients with a history of pituitary disease, surgery, or cranial radiation, the hypothalamic-pituitary axis is compromised. Therefore, TSH secretion is impaired and cannot be used as a reliable indicator of thyroid status. In these patients (who have secondary or tertiary hypothyroidism), levothyroxine replacement must be monitored using serum free T4 levels, aiming for the middle to upper half of the normal reference range. This patient presents with classic signs and symptoms of hypothyroidism (fatigue, weight gain, constipation, delayed deep tendon reflexes) and has a subnormal free T4 level (

0.7

ng/dL). This clearly indicates that he is under-replaced and requires an increase in his levothyroxine dosage. The suppressed TSH (

0.04

\mu

U/mL) is an expected consequence of his prior pituitary macroadenoma and its treatment, and it should not guide therapy.

Step-by-Step Solution

1

Identify the underlying etiology of the patient's thyroid dysfunction.

The patient has a history of a pituitary macroadenoma treated with surgery and radiation, indicating secondary (central) hypothyroidism rather than primary thyroid disease.

Understanding the level of the hypothalamic-pituitary-thyroid (HPT) axis defect is crucial because it dictates which laboratory values are reliable for monitoring therapy.

2

Analyze the current laboratory values and clinical symptoms in the context of the diagnosis.

The patient is experiencing classic symptoms of hypothyroidism (fatigue, weight gain, delayed reflexes) and has a subnormal free T4 level (

0.7

ng/dL), confirming inadequate thyroid hormone replacement.

Clinical status and free T4 levels are the primary parameters for assessing thyroid replacement adequacy in patients with central hypothyroidism.

3

Determine the appropriate management intervention based on the clinical assessment.

The levothyroxine dosage must be increased to raise the free T4 level into the middle to upper half of the normal reference range and to resolve the hypothyroid symptoms.

Because the pituitary gland is damaged, TSH secretion is permanently impaired. The suppressed TSH (

0.04

\mu

U/mL) is an expected artifact of the pituitary disease and must be ignored when titrating levothyroxine.

Key Concept

In patients with secondary (central) hypothyroidism due to pituitary or hypothalamic disease, levothyroxine replacement therapy must be monitored by measuring serum free T4 levels rather than TSH. The goal is to maintain the free T4 in the middle to upper half of the normal reference range.

Question 6487Question →

A $44$ -year-old man is evaluated in the hospital for progressive agitation and confusion. He was admitted two days ago for a severe right lower extremity cellulitis caused by methicillin-resistant Staphylococcus aureus (MRSA) and was started on intravenous linezolid. He has a history of major depressive disorder and generalized anxiety disorder, for which he takes multiple stable home medications. His temperature is $39.1^\circ\text{C}$ ( $102.4^\circ\text{F}$ ), blood pressure is $168/102$ mmHg, pulse is $124$ /min, and respirations are $22$ /min. Physical examination reveals profuse diaphoresis, bilateral mydriasis, and a resting tremor. Neurological examination is notable for pronounced hyperreflexia in the lower extremities and sustained ankle clonus. A dangerous interaction with which of the following of the patient's home medications is the most likely cause of this presentation?

Fluoxetine

Haloperidol

Bupropion

Aripiprazole

Lorazepam

Show answer & explanation

Answer: Fluoxetine

Answer

Fluoxetine

This patient's presentation of altered mental status, autonomic instability (hyperthermia, tachycardia, hypertension, diaphoresis), and prominent neuromuscular hyperactivity (hyperreflexia and clonus) is classic for serotonin syndrome. The syndrome was precipitated by the administration of linezolid. Linezolid is an antibiotic used to treat resistant Gram-positive infections (like MRSA) that also acts as a reversible, non-selective monoamine oxidase inhibitor (MAOI). When combined with a serotonergic agent like an SSRI (e.g., fluoxetine), it blocks the breakdown of serotonin, leading to massive synaptic accumulation and toxicity. Clinicians must carefully review psychiatric medication lists before initiating linezolid therapy.

Step-by-Step Solution

1

Evaluate the clinical presentation.

The patient has altered mental status, autonomic instability (fever, tachycardia, hypertension, diaphoresis), and neuromuscular hyperactivity (hyperreflexia, sustained clonus).

Identifying the clinical triad points directly to a diagnosis of serotonin syndrome.

2

Analyze the patient's recent medication changes.

The patient was recently started on intravenous linezolid for an MRSA infection.

Linezolid is an oxazolidinone antibiotic that also possesses reversible, non-selective monoamine oxidase inhibitor (MAOI) properties.

3

Identify the contraindicated home medication.

Combining an MAOI (linezolid) with a selective serotonin reuptake inhibitor (SSRI) like fluoxetine creates a dangerous drug-drug interaction.

The concurrent use of these medications leads to impaired serotonin degradation and increased serotonin release, resulting in synaptic serotonin toxicity (serotonin syndrome).

Key Concept

Serotonin syndrome can be precipitated by combining a selective serotonin reuptake inhibitor (SSRI) with linezolid, an antibiotic that possesses monoamine oxidase inhibitor (MAOI) activity.

Question 6488Question →

A 48-year-old woman is evaluated in the clinic for worsening tiredness, generalized weakness, and a 5-kg (11-lb) weight gain over the last eight months. She notes that her skin has become unusually dry, and she frequently feels cold even when others are comfortable. Her medical history is unremarkable, and she takes no medications. Vital signs are within normal limits except for a heart rate of 56/min. Physical examination reveals a diffusely enlarged, rubbery, and non-tender thyroid gland. Laboratory testing shows:

Serum TSH: 18.5 $\mu$ U/mL (Normal: 0.4-4.2)
Serum free T4: 0.5 ng/dL (Normal: 0.8-2.7)

Which of the following is the most likely underlying mechanism for this patient's clinical presentation?

Autoimmune-mediated destruction of thyroid follicular cells

Production of stimulating autoantibodies against the thyrotropin receptor

Decreased secretion of thyrotropin from the anterior pituitary gland

Peripheral resistance to circulating thyroid hormones

Granulomatous inflammation following a viral upper respiratory infection

Show answer & explanation

Answer: Autoimmune-mediated destruction of thyroid follicular cells

Answer

Autoimmune-mediated destruction of thyroid follicular cells

The correct answer accurately describes the pathophysiology of Hashimoto thyroiditis, which is the most common cause of primary hypothyroidism in iodine-sufficient areas. The patient's presentation of weight gain, fatigue, cold intolerance, bradycardia, and a diffusely enlarged, non-tender goiter is a classic clinical picture. The laboratory findings of an elevated TSH and a low free T4 confirm primary thyroid gland failure due to autoimmune-mediated destruction of the thyroid follicular cells.

Step-by-Step Solution

1

Interpret the thyroid function tests.

The patient has an elevated TSH and a decreased free T4 level.

To determine the thyroid functional status and localize the defect.

2

Diagnose the condition based on labs and symptoms.

The combination of high TSH, low free T4, weight gain, fatigue, bradycardia, and cold intolerance indicates primary hypothyroidism.

Elevated TSH with low T4 confirms the thyroid gland itself is the primary source of failure.

3

Identify the most common etiology.

Hashimoto thyroiditis (autoimmune-mediated destruction) is the most common cause of primary hypothyroidism in iodine-sufficient regions.

The presence of a painless, rubbery goiter strongly supports this autoimmune etiology.

Key Concept

Primary hypothyroidism is characterized by an elevated TSH and low free T4, most commonly due to autoimmune Hashimoto thyroiditis.

Estimated Time:1m 0s

Question 6489Question →

Match each of the following clinical conditions with its classic initial presentation of serum laboratory findings (calcium, phosphorus, and intact parathyroid hormone [PTH]).

Click a left item, then click its matching right item

Show answer & explanation

Answer

Primary hyperparathyroidism matches with elevated calcium, decreased phosphorus, elevated PTH. Hypoparathyroidism matches with decreased calcium, elevated phosphorus, decreased PTH. Chronic kidney disease matches with decreased calcium, elevated phosphorus, elevated PTH. Vitamin D deficiency matches with decreased calcium, decreased phosphorus, elevated PTH.

Calcium and phosphorus levels are primarily regulated by PTH and vitamin D. Understanding the primary defect allows prediction of the compensatory response and the resulting laboratory pattern. Primary hyperparathyroidism is driven by autonomous PTH excess (high Ca, low P). Hypoparathyroidism is defined by a lack of PTH (low Ca, high P). Chronic kidney disease features primary phosphorus retention and impaired vitamin D activation (low Ca, high P, high PTH). Vitamin D deficiency features poor gut absorption with intact renal function (low Ca, low P, high PTH).

Step-by-Step Solution

1

Analyze the laboratory profile for primary hyperparathyroidism.

Autonomous PTH production raises calcium and lowers phosphorus.

Excess PTH acts on the kidneys to reabsorb calcium and excrete phosphorus, and acts on bone to release calcium.

2

Analyze the laboratory profile for hypoparathyroidism.

Absent or low PTH results in low calcium and high phosphorus.

Without adequate PTH, the kidneys cannot adequately reabsorb calcium or excrete the daily phosphorus load.

3

Analyze the laboratory profile for chronic kidney disease.

Renal failure causes phosphorus retention and low 1,25-dihydroxyvitamin D, resulting in low calcium, high phosphorus, and compensatory high PTH.

The failing kidney cannot excrete phosphorus or properly activate vitamin D, leading to secondary hyperparathyroidism.

4

Analyze the laboratory profile for vitamin D deficiency.

Poor intestinal absorption leads to low calcium and low phosphorus, with a compensatory high PTH.

Secondary hyperparathyroidism in response to low calcium attempts to normalize serum calcium but simultaneously wastes phosphorus in the urine.

Key Concept

Calcium and Phosphorus Homeostasis

Question 6490Question →

For each patient presenting with renal dysfunction, identify the characteristic microscopic urine sediment finding that would most strongly support the underlying diagnosis.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The clinical scenarios map to their respective urinary sediment findings as follows: Ischemic ATN with muddy brown casts, Post-infectious GN with RBC casts, AIN with WBC casts, Nephrotic syndrome with fatty casts, and advanced CKD with broad waxy casts.

Each microscopic urinalysis finding acts as a distinct biomarker for the underlying pathophysiology. Granular (muddy brown) casts reflect desquamated tubular cells in ATN. RBC casts denote glomerular bleeding. WBC casts and eosinophils indicate allergic interstitial inflammation. Fatty casts occur when filtered lipoproteins are processed by tubular cells in nephrotic syndrome. Broad waxy casts form in the dilated, hypertrophic tubules of chronically diseased kidneys.

Step-by-Step Solution

1

Analyze the etiology of the 54-year-old male with shock-induced AKI.

Hypotension causes renal ischemia leading to Acute Tubular Necrosis (ATN).

ATN is characterized by the death and sloughing of tubular cells, which aggregate into muddy brown casts.

2

Evaluate the 25-year-old female with post-pharyngitis nephritic symptoms.

Presentation is consistent with post-infectious glomerulonephritis.

Glomerular inflammation leads to bleeding into the Bowman's space, forming RBC casts as they travel down the tubules.

3

Assess the 42-year-old male with fever, rash, and AKI after nafcillin use.

The classic allergic triad strongly suggests drug-induced Acute Interstitial Nephritis (AIN).

AIN causes an allergic inflammatory infiltrate in the interstitium, releasing WBCs and eosinophils into the urine.

4

Determine the syndrome for the 58-year-old male with massive edema and heavy proteinuria.

Proteinuria > 3.5 g/day confirms Nephrotic Syndrome.

Heavy proteinuria triggers hepatic lipoprotein synthesis; these lipids enter the urine forming fatty casts and oval fat bodies.

5

Interpret the 72-year-old female with long-standing diabetes and GFR of 11.

The presentation denotes End-Stage Renal Disease (ESRD) / advanced Chronic Kidney Disease.

Chronic structural damage leads to dilated tubules and low flow states, causing the formation of broad, waxy casts.

Key Concept

Correlation of microscopic urinalysis sediment findings with specific nephrologic pathophysiologies.

Question 6491Question →

A 54-year-old man is evaluated in the hospital on hospital day 3 for ongoing management of a severe skin and soft tissue infection of the right lower extremity. He initially presented with high fever, chills, and a rapidly expanding area of erythema and induration. Blood cultures drawn on admission have now returned positive for methicillin-susceptible Staphylococcus aureus (MSSA). His empiric antimicrobial regimen since admission has consisted of intravenous vancomycin and cefepime. The patient's medical record indicates an allergy to penicillin, which he describes as a flat, red rash on his chest that occurred 20 years ago when taking amoxicillin. He explicitly denies any history of facial swelling, hives, or breathing difficulties. He is currently hemodynamically stable, his temperature is 37.4°C (99.3°F), and the erythema has significantly receded. Subsequent blood cultures drawn 48 hours after admission show no growth to date.

Which of the following is the most appropriate pharmacologic intervention at this time?

Stop cefepime and maintain intravenous vancomycin

Replace the current antimicrobials with intravenous ceftaroline

Replace the current antimicrobials with intravenous cefazolin

Replace the current antimicrobials with intravenous daptomycin

Maintain the current regimen of intravenous vancomycin and cefepime

Show answer & explanation

Answer: Replace the current antimicrobials with intravenous cefazolin

Answer

Replace the current antimicrobials with intravenous cefazolin

The patient has MSSA bacteremia secondary to a skin and soft tissue infection. The drug of choice for MSSA bacteremia is an anti-staphylococcal beta-lactam, such as cefazolin or nafcillin, because these agents have been shown to provide superior clinical outcomes, faster bacterial clearance, and lower mortality compared to vancomycin. A critical decision point in this vignette is the patient's reported penicillin allergy. He experienced a non-pruritic maculopapular rash to amoxicillin 20 years ago. This is a classic non-IgE-mediated, delayed-type hypersensitivity reaction that is generally benign. Furthermore, cefazolin has a unique R1 side chain that is structurally distinct from other penicillins and cephalosporins, making the rate of cross-reactivity virtually non-existent. Therefore, the most appropriate next step in antibiotic stewardship is to de-escalate his broad-spectrum empiric regimen and transition him to intravenous cefazolin monotherapy.

Step-by-Step Solution

1

Analyze the culture and susceptibility results.

The pathogen is identified as methicillin-susceptible Staphylococcus aureus (MSSA).

Guides targeted antimicrobial de-escalation from empiric broad-spectrum therapy.

2

Evaluate the patient's penicillin allergy history.

The history of a flat, red rash 20 years ago indicates a delayed, non-IgE-mediated reaction rather than anaphylaxis.

Determines the safety of administering beta-lactam antibiotics, which are the treatment of choice for MSSA.

3

Select the optimal targeted therapy for MSSA bacteremia.

Intravenous cefazolin is selected as the definitive therapy.

Anti-staphylococcal beta-lactams are superior to vancomycin for MSSA, and cefazolin poses virtually zero cross-reactivity risk given its unique side chain.

Key Concept

Patients with methicillin-susceptible Staphylococcus aureus (MSSA) bacteremia should be treated with an anti-staphylococcal beta-lactam (e.g., cefazolin, nafcillin) rather than vancomycin due to superior clinical outcomes. A remote, non-IgE-mediated penicillin allergy is not a contraindication to cefazolin.

Estimated Time:1m 15s

Question 6492Question →

A 20-year-old woman is brought to the emergency department by her roommate due to confusion, nausea, and ringing in her ears for the past 6 hours. The patient has a history of major depressive disorder and recently went through a difficult breakup. On physical examination, she is diaphoretic and mildly disoriented. Temperature is 38.2°C (100.8°F), blood pressure is 115/75 mm Hg, pulse is 116/min, and respirations are 30/min. Lungs are clear to auscultation.

Laboratory studies show:

Parameter	Result
Serum sodium	140 mEq/L
Serum potassium	3.6 mEq/L
Serum chloride	103 mEq/L
Serum bicarbonate	13 mEq/L
Blood urea nitrogen	16 mg/dL
Serum creatinine	0.9 mg/dL

Arterial blood gas on room air:

Parameter	Result
pH	7.42
pCO2	20 mm Hg
pO2	96 mm Hg

Which of the following best describes this patient's acid-base disturbance?

Primary anion gap metabolic acidosis with appropriate respiratory compensation

Primary respiratory alkalosis with appropriate metabolic compensation

Mixed primary anion gap metabolic acidosis and primary respiratory alkalosis

Mixed primary non-anion gap metabolic acidosis and primary respiratory alkalosis

Mixed primary anion gap metabolic acidosis and primary respiratory acidosis

Show answer & explanation

Answer: Mixed primary anion gap metabolic acidosis and primary respiratory alkalosis

Answer

Mixed primary anion gap metabolic acidosis and primary respiratory alkalosis

The patient's presentation with tinnitus, tachypnea, fever, and confusion following a difficult breakup is classic for acute salicylate (aspirin) overdose. This toxicity classically causes a mixed acid-base disorder. First, calculate the anion gap:

Na^+ - (Cl^- + HCO_3^-)

=

140 - (103 + 13) = 24

mEq/L. Because this is greater than the normal range of 8-12 mEq/L, there is a primary anion gap metabolic acidosis (driven by uncoupled oxidative phosphorylation and accumulation of organic acids). Next, determine if the respiratory compensation is appropriate by using Winter's formula: Expected

pCO_2 = 1.5 \times 13 + 8 \pm 2 = 27.5 \pm 2

(25.5 to 29.5 mm Hg). The patient's actual

pCO_2

is 20 mm Hg. Because the actual

pCO_2

is lower than the expected compensatory range, she has an excessive respiratory drive, indicating a concomitant primary respiratory alkalosis (caused by salicylates directly stimulating the medullary respiratory center). Therefore, this is a mixed primary anion gap metabolic acidosis and primary respiratory alkalosis.

Step-by-Step Solution

1

Calculate the anion gap to determine the primary metabolic disturbance.

Anion Gap =

Na^+ - (Cl^- + HCO_3^-)

=

140 - (103 + 13)

=

24

mEq/L.

An elevated anion gap (normal 8-12 mEq/L) establishes the presence of a primary anion gap metabolic acidosis.

2

Apply Winter's formula to determine the expected respiratory compensation.

Expected

pCO_2 = 1.5 \times [HCO_3^-] + 8 \pm 2

=

1.5 \times 13 + 8 \pm 2

=

27.5 \pm 2

(range 25.5 to 29.5 mm Hg).

In a metabolic acidosis, the respiratory system compensates by increasing ventilation to lower the

pCO_2

. Winter's formula calculates the precise expected limit of this compensation.

3

Compare the actual measured

pCO_2

to the expected

pCO_2

range.

The patient's actual

pCO_2

(20 mm Hg) is significantly lower than the expected range (25.5 - 29.5 mm Hg).

Because the

pCO_2

is driven down further than metabolic compensation alone would cause, a concomitant primary respiratory alkalosis must also be present.

Key Concept

Salicylate toxicity classically presents with a mixed primary anion gap metabolic acidosis (due to uncoupled oxidative phosphorylation) and primary respiratory alkalosis (due to direct stimulation of the medullary respiratory center). This is diagnosed by identifying an elevated anion gap and noting that the actual

pCO_2

is lower than the predicted range using Winter's formula.

Question 6493Question →

A 28-year-old nulligravid woman comes to the office due to an inability to conceive over the past 14 months despite regular, unprotected intercourse. Her menstrual periods were previously regular every 28 days but became increasingly spaced apart starting 8 months ago. She has had no menses for the last 4 months. The patient also reports a recent onset of constipation, generalized fatigue, and a 4.5-kg (10-lb) weight gain. She takes no medications. Vital signs are temperature 36.4°C (97.5°F), blood pressure 110/70 mm Hg, and pulse 58/min. BMI is $27\ kg/m^2$ . Physical examination reveals a moderately enlarged, non-tender thyroid gland and bilateral milky nipple discharge expressible on palpation. Neurologic examination shows delayed relaxation of the deep tendon reflexes. A urine pregnancy test is negative.

Laboratory studies show:
- Prolactin: 58 ng/mL (normal: <25 ng/mL)
- Thyroid-stimulating hormone (TSH): 18.2 µU/mL (normal: 0.4-4.0 µU/mL)
- Free thyroxine (T4): 0.5 ng/dL (normal: 0.8-1.8 ng/dL)

Which of the following is the most appropriate next step in management for this patient?

Initiation of levothyroxine

Initiation of cabergoline

Magnetic resonance imaging of the pituitary

Measurement of serum testosterone and dehydroepiandrosterone sulfate

Clomiphene citrate therapy

Show answer & explanation

Answer: Initiation of levothyroxine

Answer

Initiation of levothyroxine

The correct answer is initiation of levothyroxine. This patient presents with secondary amenorrhea, galactorrhea, and infertility in the setting of primary hypothyroidism (elevated TSH, low free T4). In primary hypothyroidism, the lack of negative feedback from thyroid hormones leads to increased hypothalamic production of Thyrotropin-Releasing Hormone (TRH). TRH stimulates not only thyrotrophs (increasing TSH) but also lactotrophs in the anterior pituitary, leading to hyperprolactinemia. Elevated serum prolactin inhibits the pulsatile secretion of Gonadotropin-Releasing Hormone (GnRH), resulting in decreased FSH and LH, anovulation, and secondary amenorrhea. Treating the root cause with levothyroxine will normalize free T4 and TSH levels, thereby decreasing TRH, resolving the hyperprolactinemia, and restoring normal ovulatory cycles without the need for further fertility treatments.

Step-by-Step Solution

1

Identify the primary diagnosis based on clinical presentation and laboratory results.

The patient has weight gain, fatigue, bradycardia, delayed reflexes, elevated TSH, and low free T4, confirming overt primary hypothyroidism.

Establishing the root cause of the endocrine disturbance is necessary before treating downstream effects.

2

Connect the primary diagnosis to the secondary reproductive symptoms.

Primary hypothyroidism causes increased Thyrotropin-Releasing Hormone (TRH). TRH directly stimulates lactotrophs in the anterior pituitary, leading to mild hyperprolactinemia and galactorrhea. Elevated prolactin inhibits GnRH secretion, causing amenorrhea and infertility.

Understanding the physiological axis explains why multiple endocrine abnormalities are present.

3

Determine the next best step in management.

Treat the root cause by initiating thyroid hormone replacement (levothyroxine).

Correcting the hypothyroidism will normalize TRH levels, resolve the hyperprolactinemia, and restore normal ovulatory cycles.

Key Concept

Primary hypothyroidism can cause secondary hyperprolactinemia due to TRH-mediated stimulation of pituitary lactotrophs, leading to anovulation and infertility that resolves with levothyroxine therapy.

Question 6494Question →

A $66$ -year-old man is brought to the emergency department by his daughter due to a $3$ -day history of progressively worsening shortness of breath and a persistent cough. He notes his baseline morning cough has increased in frequency, and his sputum has changed from clear to thick and yellowish-green. His medical history is significant for severe chronic obstructive pulmonary disease (COPD), hypertension, and hypothyroidism (managed with levothyroxine). He has a $45$ -pack-year smoking history. His temperature is $37.8^\circ\text{C}$ ( $100.0^\circ\text{F}$ ), pulse is $114/\text{min}$ , blood pressure is $145/88\text{ mm Hg}$ , respiratory rate is $28/\text{min}$ , and oxygen saturation is $86\%$ on room air.

Physical examination reveals a barrel-shaped chest with accessory muscle use. Pulmonary auscultation demonstrates a prolonged expiratory phase, diffuse expiratory wheezes, and scattered rhonchi, but no crackles are heard. The jugular venous pressure is elevated at $10\text{ cm H}_2\text{O}$ . Abdominal examination shows a liver edge that is palpable $3\text{ cm}$ below the right costal margin and is mildly tender. Trace bilateral lower extremity pitting edema is present.

Laboratory studies show:
Leukocyte count: $11,500/\text{mm}^3$
Serum sodium: $139\text{ mEq/L}$
Serum potassium: $4.1\text{ mEq/L}$
Serum bicarbonate: $31\text{ mEq/L}$
Blood urea nitrogen: $18\text{ mg/dL}$
Serum creatinine: $0.9\text{ mg/dL}$
Thyroid-stimulating hormone (TSH): $0.2\text{ \mu U/mL}$ (Normal: $0.4-4.0\text{ \mu U/mL}$ )
Free T4: $1.2\text{ ng/dL}$ (Normal: $0.9-1.7\text{ ng/dL}$ )

Arterial blood gas analysis on room air shows a pH of $7.31$ , $\text{PaCO}_2$ of $62\text{ mm Hg}$ , and $\text{PaO}_2$ of $54\text{ mm Hg}$ .

Chest radiography reveals hyperinflated lung fields, flattened diaphragms, and an enlarged right descending pulmonary artery. There are no pleural effusions or focal alveolar opacities.

Which of the following is the most appropriate next step in management for this patient?

Inhaled albuterol and ipratropium, systemic glucocorticoids, and oral azithromycin

Intravenous furosemide and noninvasive positive-pressure ventilation

Intravenous piperacillin-tazobactam and intravenous vancomycin

Intravenous sodium bicarbonate infusion

Discontinuation of current levothyroxine therapy

Show answer & explanation

Answer: Inhaled albuterol and ipratropium, systemic glucocorticoids, and oral azithromycin

Answer

The most appropriate management is the administration of inhaled albuterol and ipratropium, systemic glucocorticoids, and a macrolide antibiotic such as oral azithromycin.

The correct approach targets the primary pathophysiology of an acute chronic obstructive pulmonary disease (COPD) exacerbation. This patient presents with all three cardinal symptoms (increased dyspnea, increased sputum volume, and increased sputum purulence) requiring the standard triad of therapy: short-acting bronchodilators (albuterol and ipratropium) to relieve bronchospasm, systemic glucocorticoids to reduce airway inflammation, and an antibiotic (such as a macrolide or respiratory fluoroquinolone) to treat the likely bacterial trigger. Although the patient has signs of fluid overload, these are due to cor pulmonale (right-sided heart failure secondary to chronic pulmonary hypertension) rather than left-sided heart failure, making aggressive diuresis incorrect and potentially harmful.

Step-by-Step Solution

1

Analyze the patient's acute respiratory presentation and history.

The patient has a history of COPD and presents with the classic triad of an acute exacerbation: increased dyspnea, increased sputum volume, and increased sputum purulence.

Identifying the primary acute pathology is required to guide immediate life-saving therapy.

2

Differentiate the cause of the fluid overload signs (elevated JVP, hepatomegaly).

The physical exam shows right-sided fluid overload but no left-sided fluid overload (lungs lack crackles, CXR lacks pulmonary edema). This indicates cor pulmonale due to chronic hypoxia, not acute decompensated left heart failure.

Distinguishing right heart failure from left heart failure ensures the correct pathology (lungs vs. left ventricle) is targeted.

3

Interpret the arterial blood gas (ABG) and endocrine labs in context.

The ABG shows acute-on-chronic respiratory acidosis, requiring bronchodilators to improve ventilation. The low TSH with normal Free T4 represents euthyroid sick syndrome, requiring no intervention.

Accurate interpretation of confounding laboratory abnormalities prevents the administration of inappropriate and potentially harmful treatments.

Key Concept

Management of acute COPD exacerbation complicated by cor pulmonale

Question 6495Question →

A thirty-five-year-old female is referred for endocrinologic evaluation due to progressive central weight gain, severe exhaustion, proximal muscle weakness, and easy bruising over the past seven months. Physical examination reveals a blood pressure of $162/98$ mm Hg, marked facial plethora, supraclavicular fat accumulation, and broad, violaceous abdominal striae. Arrange the following interventions in the most appropriate chronological sequence for the complete diagnostic workup and definitive management of this condition. Assume the patient ultimately has pituitary-dependent hypercortisolism, but any causative lesion identified on initial imaging is $< 5$ mm in diameter.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct sequence is: (1) 1-mg overnight dexamethasone suppression test, (2) Plasma ACTH measurement, (3) Pituitary MRI, (4) Inferior petrosal sinus sampling (IPSS), and (5) Transsphenoidal surgery.

The evaluation of Cushing syndrome requires a rigorous, stepwise approach to prevent diagnostic errors. First, endogenous hypercortisolism must be confirmed, typically using a 1-mg overnight dexamethasone suppression test, 24-hour urine free cortisol, or late-night salivary cortisol. Once confirmed, the next step is measuring plasma ACTH to determine if the disease is ACTH-dependent (normal/elevated ACTH) or ACTH-independent (suppressed ACTH). For ACTH-dependent disease, a pituitary MRI is performed. Because incidental, non-functioning pituitary microadenomas are common in the general population, finding a lesion smaller than 6 mm on MRI is insufficient for diagnosis. In such cases, bilateral inferior petrosal sinus sampling (IPSS) with CRH stimulation must be performed to definitively confirm that the pituitary is the source of excess ACTH (Cushing disease) rather than an ectopic source. Finally, once a central source is biochemically confirmed by a central-to-peripheral ACTH gradient, transsphenoidal surgical resection is the definitive treatment.

Step-by-Step Solution

1

Establish the presence of endogenous hypercortisolism

The 1-mg overnight dexamethasone suppression test is performed as an initial screen.

Before determining the etiology, pathologic hypercortisolism must be biochemically confirmed to rule out normal physiology or pseudo-Cushing states.

2

Determine ACTH dependence

Early morning plasma ACTH concentration is measured.

This distinguishes between ACTH-independent (adrenal) and ACTH-dependent (pituitary or ectopic) sources of hypercortisolism.

3

Localize the source of ACTH production

A high-resolution MRI of the pituitary gland is obtained.

For ACTH-dependent disease, the pituitary is the most common source, making MRI the first-line imaging modality.

4

Confirm central ACTH secretion when imaging is equivocal

Bilateral IPSS with CRH stimulation is performed.

Since up to 10% of healthy individuals have incidental pituitary microadenomas, an adenoma < 6 mm is not definitive proof of Cushing disease. IPSS is required to rule out an ectopic source.

5

Provide definitive therapy

Transsphenoidal surgical resection is performed.

Once the central source is biochemically confirmed via IPSS, surgical removal of the adenoma is the treatment of choice.

Key Concept

The diagnostic algorithm for Cushing syndrome proceeds strictly from biochemical confirmation, to determining ACTH dependence, to anatomic localization, and finally to resolving imaging ambiguity with venous sampling before surgery.

Estimated Time:2m 30s

Question 6496Question →

Match each clinical presentation with the most likely corresponding coagulation panel findings.

Click a left item, then click its matching right item

Show answer & explanation

Answer

Hemophilia matches with isolated prolonged aPTT. von Willebrand disease matches with prolonged aPTT and prolonged bleeding time. Disseminated intravascular coagulation matches with globally prolonged coagulation times and consumptive markers (decreased platelets and fibrinogen). Vitamin K antagonism matches with isolated prolonged PT.

Each underlying clinical condition produces a distinct and predictable pattern of laboratory abnormalities based on the specific phase of hemostasis that is disrupted.

Step-by-Step Solution

1

Analyze the first clinical vignette (14-year-old boy).

Identify a sex-linked bleeding disorder affecting deep tissues (hemarthrosis), indicating Hemophilia.

Hemophilia A and B are intrinsic pathway factor deficiencies that manifest with deep tissue and joint bleeding.

2

Determine the laboratory profile for Hemophilia.

Matches with prolonged aPTT, normal PT, and normal bleeding time.

Deficiencies in factors VIII or IX specifically prolong the intrinsic pathway measurement (aPTT) without affecting primary platelet plug formation.

3

Analyze the second clinical vignette (22-year-old woman).

Identify a mucosal bleeding pattern (menorrhagia, epistaxis), indicating von Willebrand disease.

von Willebrand disease affects primary hemostasis and factor VIII stabilization.

4

Determine the laboratory profile for von Willebrand disease.

Matches with prolonged bleeding time and prolonged aPTT, with normal PT.

Impaired platelet adhesion prolongs bleeding time, and reduced factor VIII prolongs aPTT.

5

Analyze the third clinical vignette (ICU patient with bacteremia).

Identify a consumptive coagulopathy indicative of disseminated intravascular coagulation (DIC).

Sepsis triggers systemic, uncontrolled coagulation activation.

6

Determine the laboratory profile for disseminated intravascular coagulation.

Matches with prolonged PT, prolonged aPTT, decreased platelet count, and decreased fibrinogen.

Systemic consumption universally depletes all coagulation factors, fibrinogen, and platelets.

7

Analyze the fourth clinical vignette (patient with mechanical valve).

Identify the use of a vitamin K antagonist (warfarin) causing supratherapeutic bleeding.

Patients with mechanical valves require chronic anticoagulation, typically managed with warfarin.

8

Determine the laboratory profile for vitamin K antagonism.

Matches with prolonged PT, normal or mildly prolonged aPTT, and normal bleeding time.

Warfarin rapidly depletes factor VII, markedly prolonging the extrinsic pathway measurement (PT).

Key Concept

Differentiation of coagulation disorders requires analyzing both the coagulation cascade (PT and aPTT) and primary hemostasis mechanisms (platelet count and bleeding time).

Question 6497Question →

A 24-year-old G1P0 woman at 39 weeks of gestation is evaluated in the labor suite. She was admitted 4 hours ago in spontaneous active labor and is currently not receiving any medications. Her temperature is 37.1°C (98.8°F), blood pressure is 118/72 mm Hg, pulse is 88/min, and respirations are 16/min. Physical examination reveals mild bilateral lower extremity pitting edema and a grade 2/6 systolic ejection murmur at the left sternal border. The cervix is 6 cm dilated and 90% effaced, with the fetal vertex at 0 station. Fetal heart rate monitoring demonstrates a baseline of 140/min with moderate variability. Over the last 30 minutes, there are recurrent, symmetric decreases in the fetal heart rate that begin gradually with the onset of each uterine contraction, reach their nadir of 120/min exactly at the peak of the contraction, and return to the baseline as the contraction ends. Which of the following is the most appropriate next step in management?

Reposition the patient and administer an intravenous fluid bolus

Continue routine expectant management of labor

Administer intravenous magnesium sulfate

Prepare for immediate cesarean delivery

Administer intravenous terbutaline

Show answer & explanation

Answer: Continue routine expectant management of labor

Answer

The correct answer is to continue routine expectant management of labor, as the patient has normal physiologic changes of pregnancy and a reassuring fetal heart rate tracing.

This patient has a reassuring Category I fetal heart rate (FHR) tracing characterized by a normal baseline, moderate variability, and early decelerations. Early decelerations are symmetrical, gradual decreases in the FHR that perfectly mirror uterine contractions—meaning the nadir of the deceleration occurs simultaneously with the peak of the contraction. They are caused by physiologic fetal head compression during contractions, which alters cerebral blood flow and triggers a benign vagal response. Because this is a normal finding in active labor, no acute intervention is required, and continuing routine expectant management is the correct next step. Furthermore, her mild peripheral edema and grade 2/6 systolic ejection murmur are normal physiologic adaptations to pregnancy (arising from increased plasma volume and decreased systemic vascular resistance) and do not represent a pathological complication.

Step-by-Step Solution

1

Evaluate the maternal vital signs and physical examination findings.

The blood pressure is normal (118/72 mm Hg). The mild lower extremity edema and systolic ejection murmur are identified as benign, physiologic adaptations to pregnancy.

Differentiating normal physiologic changes of pregnancy from pathological states (like preeclampsia or heart failure) prevents unnecessary and potentially harmful interventions.

2

Interpret the fetal heart rate (FHR) tracing.

The baseline is 140/min, variability is moderate, and decelerations exactly mirror the uterine contractions (the nadir aligns with the peak of the contraction).

Accurate interpretation of the FHR tracing is required to classify it into a specific category and determine fetal well-being.

3

Identify the etiology of the FHR decelerations based on the timing relative to contractions.

The pattern describes early decelerations, which are caused by physiologic fetal head compression altering cerebral blood flow and triggering a benign vagal response.

Understanding the pathophysiology of decelerations dictates the clinical response. Early decelerations are normal and part of a Category I tracing.

4

Determine the appropriate clinical intervention.

Because both the maternal clinical status and the fetal tracing are reassuring, no acute intervention is required.

A Category I tracing indicates normal fetal acid-base status and warrants routine expectant management.

Key Concept

Early fetal heart rate decelerations (symmetrical decreases mirroring contractions) are a benign finding caused by fetal head compression and require no intervention.

Question 6498Question →

A consultation-liaison psychiatry team is reviewing common adverse effects of various psychotropic medications to update hospital safety protocols. Match each clinical presentation of an adverse drug reaction with the medication most likely responsible.

Click a left item, then click its matching right item

Show answer & explanation

Answer

The presentations match as follows: polyuria/tremor/hypothyroidism with Lithium; sialorrhea/seizures/neutropenia with Clozapine; mucosal blistering rash with Lamotrigine; and hyperammonemic encephalopathy with Valproate.

Each psychotropic medication has a distinct adverse effect profile that is critical for clinical monitoring. Lithium causes nephrogenic diabetes insipidus and hypothyroidism. Clozapine causes agranulocytosis and lowers the seizure threshold. Lamotrigine can cause Stevens-Johnson syndrome. Valproate can cause hyperammonemic encephalopathy and hepatotoxicity.

Step-by-Step Solution

1

Analyze the first clinical presentation (polyuria, tremor, elevated TSH).

Identified as lithium-induced adverse effects.

Lithium affects renal concentrating ability (nephrogenic DI) and thyroid gland function, and commonly causes a fine tremor.

2

Analyze the second presentation (sialorrhea, seizures, neutropenia).

Identified as clozapine toxicity.

Clozapine is unique among antipsychotics for causing agranulocytosis, hypersalivation, and a significantly increased risk of seizures.

3

Analyze the third presentation (mucosal blistering, epidermal detachment).

Identified as Stevens-Johnson syndrome/Toxic epidermal necrolysis caused by lamotrigine.

Lamotrigine is strongly associated with life-threatening rashes, particularly if titrated too rapidly.

4

Analyze the fourth presentation (hyperammonemia, hepatotoxicity, asterixis).

Identified as valproate-induced hyperammonemic encephalopathy.

Valproate interferes with the urea cycle, leading to hyperammonemia and subsequent encephalopathy presenting with asterixis.

Key Concept

Adverse effect profiles of psychotropic medications

Question 6499Question →

A 42-year-old man presents to the emergency department with a 3-day history of severe nausea, nonbilious vomiting, and diffuse abdominal pain. He has a history of poorly controlled type 1 diabetes mellitus. His temperature is $37.2^\circ\text{C}$ ( $99.0^\circ\text{F}$ ), blood pressure is $90/60\text{ mm Hg}$ , pulse is $118/\text{min}$ , and respirations are $26/\text{min}$ . Physical examination reveals dry mucous membranes, decreased skin turgor, and a diffusely tender abdomen without rebound or guarding.

Laboratory studies show the following:
Serum sodium: $142\text{ mEq/L}$
Serum potassium: $3.2\text{ mEq/L}$
Serum chloride: $92\text{ mEq/L}$
Serum bicarbonate: $14\text{ mEq/L}$
Blood glucose: $550\text{ mg/dL}$
Serum blood urea nitrogen: $45\text{ mg/dL}$
Serum creatinine: $1.8\text{ mg/dL}$

Assuming a normal serum anion gap of $12\text{ mEq/L}$ and a normal serum bicarbonate of $24\text{ mEq/L}$ , what is this patient's delta-delta ratio ( $\Delta\text{AG} / \Delta\text{HCO}_3^-$ )?

Show answer & explanation

Answer: 2.4

Answer

The patient's delta-delta ratio is 2.4.

This patient presents with diabetic ketoacidosis (DKA), which causes a high anion gap metabolic acidosis (HAGMA). He also has a history of severe vomiting, which typically causes a metabolic alkalosis due to loss of gastric hydrochloric acid. To uncover this mixed disorder, the delta-delta ratio is calculated. The measured anion gap is

142 - (92 + 14) = 36\text{ mEq/L}

. The change in the anion gap (

\Delta\text{AG}

) is

36 - 12 = 24\text{ mEq/L}

. The change in bicarbonate (

\Delta\text{HCO}_3^-

) is

24 - 14 = 10\text{ mEq/L}

. The delta-delta ratio is

24 / 10 = 2.4

. In a pure HAGMA, the drop in bicarbonate should roughly equal the rise in the anion gap (ratio of

1.0

to

2.0

). A ratio greater than

2.0

confirms that the bicarbonate has not dropped as much as expected, indicating the presence of a concurrent metabolic alkalosis, consistent with his history of vomiting.

Step-by-Step Solution

1

Calculate the patient's measured serum anion gap.

\text{AG} = 142 - (92 + 14) = 36\text{ mEq/L}

Calculating the anion gap is the first step in analyzing any acid-base disorder to determine if unmeasured anions are present.

2

Calculate the change in anion gap (

\Delta\text{AG}

).

\Delta\text{AG} = 36 - 12 = 24\text{ mEq/L}

This value represents the excess unmeasured anions (such as ketones) added to the blood.

3

Calculate the change in serum bicarbonate (

\Delta\text{HCO}_3^-

).

\Delta\text{HCO}_3^- = 24 - 14 = 10\text{ mEq/L}

This value represents how much bicarbonate was consumed to buffer the excess acid.

4

Calculate the delta-delta ratio.

\Delta\text{Ratio} = \frac{24}{10} = 2.4

The ratio of

\Delta\text{AG}

to

\Delta\text{HCO}_3^-

reveals whether the change in the anion gap corresponds to the drop in bicarbonate. A ratio greater than 2.0 indicates an underlying concurrent metabolic alkalosis.

Key Concept

The delta-delta ratio is used to identify mixed acid-base disorders in the presence of a high anion gap metabolic acidosis. A ratio greater than 2.0 indicates a concurrent metabolic alkalosis.

Question 6500Question →

A 35-year-old nulligravid woman with a history of severe endometriosis is undergoing her first in vitro fertilization (IVF) cycle using a standard gonadotropin-releasing hormone (GnRH) antagonist protocol. Arrange the following pharmacological interventions and clinical steps of the IVF cycle in the correct chronological sequence, starting from the beginning of ovarian stimulation to the post-retrieval phase.

Drag items to arrange them in the correct order

Show answer & explanation

Answer

The correct chronological sequence for a standard GnRH antagonist IVF cycle is: 1) Exogenous FSH, 2) GnRH antagonist, 3) hCG trigger, 4) Oocyte retrieval, 5) Supplemental progesterone.

In a GnRH antagonist IVF cycle, the treatment begins with exogenous FSH to stimulate multifollicular growth. As follicles enlarge and estradiol levels rise, a GnRH antagonist is introduced (usually on stimulation day 5 or 6) to immediately block pituitary GnRH receptors, preventing a premature LH surge and spontaneous ovulation. Once ultrasound confirms the leading follicles have reached a mature diameter (18-20 mm), an hCG injection is given to mimic the natural LH surge, which induces final oocyte maturation and the resumption of meiosis. Transvaginal oocyte retrieval is strictly scheduled 34-36 hours post-hCG, just prior to expected follicular rupture. Finally, because the physical retrieval process depletes granulosa cells and the patient's endogenous pituitary function was suppressed, the resulting corpus luteum is inadequate; therefore, exogenous progesterone is mandatory for luteal phase support to allow for successful embryo implantation.

Step-by-Step Solution

1

Identify the goal of the initial phase of the IVF cycle.

The first step is to stimulate multiple follicles using exogenous FSH.

Natural cycles typically yield one dominant follicle; IVF requires multi-follicular development to maximize oocyte yield.

2

Determine the necessary intervention as follicles mature and estrogen levels rise.

A GnRH antagonist must be initiated.

Rising estrogen from multiple developing follicles would normally trigger an LH surge, causing premature ovulation and cycle cancellation. The GnRH antagonist prevents this.

3

Identify the step required for final oocyte maturation once follicles are large enough.

An hCG 'trigger' is administered.

Oocytes must resume meiosis I and detach from the follicular wall, which is naturally driven by the LH surge and mimicked here by hCG.

4

Determine the timing of the procedural harvesting of the oocytes.

Transvaginal oocyte retrieval is performed.

This must be precisely timed (34-36 hours post-trigger) to capture mature oocytes just before they are naturally ovulated into the pelvis.

5

Identify the final required pharmacological support.

Initiation of supplemental progesterone.

The natural luteal phase is defective in IVF cycles due to the aspiration of hormone-producing granulosa cells and previous pituitary suppression, requiring exogenous support for endometrial preparation.

Key Concept

Pharmacological sequence and endocrinological rationale of controlled ovarian hyperstimulation in In Vitro Fertilization (IVF)

Estimated Time:1m 30s

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept

Common Mistakes

Answer

Step-by-Step Solution

Key Concept